Medistim AsaOSL: MEDI

MEDI: Record revenue and EBIT margin in 2025, driven by global growth and innovation

· Issued by Medistim Asa

Record 2025 revenue of NOK 700 million and 28% EBIT margin, with strong growth across all regions and segments. Major investments in R&D, new product launches, and expanded direct sales presence position the company for continued global expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Medistim Asa

All Medistim Asa news releases